← Leaderboards
Ednan K. Bajwa
Massachusetts General Hospital
$2,022,311
Attributed
$2,022,311
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $667.2K · FY2008–15$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,022,311 · 2
By mechanism
R01$1,313,561 · 1
K23$708,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Charles A Hales$9,896,268
- Benjamin D Medoff$9,952,016
- Michelle Ng Gong$11,453,323
- Guido Musch$3,617,611
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisResearch PersonnelFunctional DisorderMortality Vital StatisticsPhenotypeClinical ResearchLungEffective TherapyAdult Respiratory Distress SyndromeEnrollmentCritical CareCaspase-3AllelesDiabetes MellitusFellowshipCohortCandidate Disease GeneDiagnosticAcute Respiratory FailureCardiacBaseCareerBronchoalveolar LavageC-Reactive Protein
Grant awards (7)
Use of advanced imaging techniques to improve diagnostic methods for ARDS$667,217
R01 · FY2015 · HL · contact PI
Use of advanced imaging techniques to improve diagnostic methods for ARDS$646,344
R01 · FY2014 · HL · contact PI
Molecular Markers of Risk, Phenotype, and Outcomes in ARDS$141,750
K23 · FY2012 · HL · contact PI
Molecular Markers of Risk, Phenotype, and Outcomes in ARDS$141,750
K23 · FY2011 · HL · contact PI
Molecular Markers of Risk, Phenotype, and Outcomes in ARDS$141,750
K23 · FY2010 · HL · contact PI
Molecular Markers of Risk, Phenotype, and Outcomes in ARDS$141,750
K23 · FY2009 · HL · contact PI
Molecular Markers of Risk, Phenotype, and Outcomes in ARDS$141,750
K23 · FY2008 · HL · contact PI